November 3, 2026 · Medicare · By Pioneer Eagle

Medicare’s $50 GLP-1 Bridge: What Older Adults Should Know Before December 2027

If you follow the news about weight-loss medicines at all, you have seen the prices — often more than $1,300 a month at list price. So the headline deserves a second look: since July 1, 2026, a temporary federal program called the Medicare GLP-1 Bridge has let eligible Medicare members get certain prescription weight-management medicines for a flat $50 a month. Here is what the program is, who it is actually for, and the catch everyone should know about — it ends on December 31, 2027.

What the Bridge is — and why it exists

Under federal law, Medicare Part D plans are not allowed to cover medicines when they are prescribed for weight loss. That is why, for years, the answer for these drugs on Medicare was simply “not covered.” The Bridge is the government’s workaround: it is a temporary demonstration program run directly by the Centers for Medicare & Medicaid Services (CMS), and it operates outside the standard Part D benefit. Your Part D plan is not the one approving or paying for these prescriptions under the Bridge — CMS runs it through a single central process instead.

The program runs from July 1, 2026 through December 31, 2027. A longer-term approach, called the BALANCE model, has been discussed, but it is not in place, and there is no confirmed successor once the Bridge ends. Treat December 2027 as a real deadline, not a formality.

What it costs

• $50 for a one-month supply — the same for every participant, whatever your income.
• The $50 does not count toward your Part D deductible or your yearly out-of-pocket maximum.
• Extra Help does not reduce it. The Low-Income Subsidy that lowers many Part D costs does not apply here, because the Bridge sits outside the Part D benefit — even people who normally pay only a few dollars per prescription pay the full $50.

For scale: the manufacturers agreed to supply these medicines to the program at a negotiated net price of about $245 a month, and list prices have run above $1,300 a month. People under 65 paying cash on their own generally face several hundred dollars a month even with direct-to-consumer discounts. That gap is exactly why this program made news.

Which medicines are covered

The Bridge covers three medicines, and only when they are prescribed for weight management:

• Wegovy (semaglutide) — both the weekly injection and the tablet.
• Zepbound (tirzepatide) — the KwikPen form only. The single-dose pens and vials are not covered.
• Foundayo (orforglipron) — a daily tablet.

Just as important is what is not on the list. Ozempic, Mounjaro, Rybelsus, and Trulicity are not covered under the Bridge — those are diabetes medicines, and coverage for them runs through your regular Part D plan. And no compounded products are covered at all: the Bridge covers the approved brand-name medicines only.

Who qualifies — and who does not

The Bridge is not open to everyone on Medicare. To qualify, you must:

• Be enrolled in a Medicare Part D plan;
• Have the medicine prescribed for weight management; and
• Meet CMS’s clinical eligibility tiers — for example, a body mass index (BMI) of 27 or higher together with a related condition such as heart disease or prediabetes, or a higher BMI on its own. The exact tiers are set by CMS and applied during the approval review.

An analysis by KFF estimates that about 3.8 million Part D enrollees meet the criteria — a large number, but a clear minority of everyone on Medicare. If you do not meet the tiers, the $50 price does not apply to you.

One more boundary matters. If you are using a GLP-1 medicine for type 2 diabetes, for moderate-to-severe obstructive sleep apnea, or for MASH (a serious liver condition), you are not routed through the Bridge at all — you stay on your regular Part D pathway, where your plan’s own rules and costs apply.

How it works, step by step

1. Talk with your doctor. The prescription has to be written for weight management, and your doctor confirms whether you fit the eligibility tiers.
2. Your doctor submits a prior authorization request — not to your Part D plan, but to a central processor run by a CMS contractor (Humana administers it). Do not be surprised if the pharmacy’s first billing attempt is rejected; that rejection is what kicks off the authorization process.
3. Once approved, you pay $50 at the pharmacy for each one-month supply, for as long as your approval and the program last.

Questions to ask your doctor

1. “Do I meet the Bridge’s eligibility tiers as you understand them?”
2. “Given my other conditions and prescriptions, is a medicine in this class a reasonable thing for us to consider at all?”
3. “The program ends December 31, 2027, with no confirmed successor. If we start, what is our plan for when it ends?”
4. “How will we follow up — weight, blood sugar, nutrition, strength — and how often?”
5. “If I don’t qualify for the Bridge, what are my real options, and what would each cost?”

The bottom line

The Medicare GLP-1 Bridge is genuinely unusual: a $50 flat price on medicines that cost many people several hundred dollars a month or more. But it is narrow — specific medicines, specific eligibility tiers, a prior authorization handled outside your drug plan — and it is temporary, ending December 31, 2027. If you think you might qualify, the right first step is a conversation with your doctor, and the right place for official details is Medicare itself: Medicare.gov/glp1bridge or 1-800-MEDICARE (1-800-633-4227).

Sources

• Centers for Medicare & Medicaid Services / Medicare.gov — Medicare GLP-1 Bridge program pages (medicare.gov/glp1bridge).
• National Council on Aging (NCOA) — “Expanding Access to Weight-Loss Medications: The Medicare GLP-1 Bridge Program.”
• KFF — analysis of Bridge eligibility (approximately 3.8 million Part D enrollees).
• Pharmacy Times and Drugs.com — reporting on the Bridge’s cost-sharing rules, covered products, and the central authorization process.